BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonomini M, Sirolli V, Dottori S, Amoroso L, Di Liberato L, Arduini A. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia. Nephrol Dial Transplant. 2007;22:2623-2629. [PMID: 17478491 DOI: 10.1093/ndt/gfm212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadi M, Hajhossein Talasaz A, Alidoosti M. Preventive effect of l-carnitine and its derivatives on endothelial dysfunction and platelet aggregation. Clinical Nutrition ESPEN 2016;15:1-10. [DOI: 10.1016/j.clnesp.2016.06.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
2 Chen Y, Abbate M, Tang L, Cai G, Gong Z, Wei R, Zhou J, Chen X. L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. Am J Clin Nutr 2014;99:408-22. [PMID: 24368434 DOI: 10.3945/ajcn.113.062802] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
3 Deyhim MR, Yari F, Mesbah-Namin SA, Khoshnaghsh F. Protective effect of L-carnitine on platelet apoptosis during storage of platelet concentrate. Transfus Clin Biol 2020;27:139-46. [PMID: 32544525 DOI: 10.1016/j.tracli.2020.06.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
5 Nassiri A, Dashti-khavidaki S, Khalili H, Nassiri-toosi M, Abdollahi A. Serum carnitine level and its associated factors in patients with chronic viral hepatitis. Future Virology 2014;9:373-83. [DOI: 10.2217/fvl.14.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Lutz J, Jurk K. Platelets and Renal Disorders. In: Gresele P, Kleiman NS, Lopez JA, Page CP, editors. Platelets in Thrombotic and Non-Thrombotic Disorders. Cham: Springer International Publishing; 2017. pp. 1183-94. [DOI: 10.1007/978-3-319-47462-5_79] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Saluk-Juszczak J, Olas B, Wachowicz B, Glowacki R, Bald E. L-carnitine modulates blood platelet oxidative stress. Cell Biol Toxicol. 2010;26:355-365. [PMID: 20069352 DOI: 10.1007/s10565-009-9148-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]